Maintenance therapy in patients with ulcerative colitis
Orchard, T., et al. - British Society of Gastroenterology guidelines recommend that all patients with ulcerative colitis should receive long-term therapy with a 5-aminosalicylic acid compound to maintain remission...Accumulating evidence suggests that the next revision of the clinical guidelines should suggest life-long doses of 5-aminosalicylic acid of >=2 g/day for maintenance of remission in patients with ulcerative colitis [more...]
|
|
|
